Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

13/04/2018 09:00

Apr 13 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 28, 2018        Feb 28, 2017     May 31, 2018 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               40.94               37.95            54.60    
                   (+7.9 pct)          (+8.2 pct)       (+3.1 pct)  
  Operating          958 mln             271 mln            1.02    
                  (+252.6 pct)         (-62.6 pct)     (+129.2 pct) 
  Recurring          890 mln             182 mln          890 mln   
                  (+387.2 pct)         (-69.7 pct)     (+174.5 pct) 
  Net                238 mln          loss 230 mln        205 mln   
  EPS               26.36 yen        loss 25.56 yen      22.68 yen  
  EPS Diluted       25.51 yen                                       
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T